MMT 2

CLINICAL SUPERVISION PROCEDURE (Version 1)

F:\PHARMACISTS\Pharmacists Procedure documents\MMT2 Clinical Supervision Procedure\Clinical Supervision Procedure-MMT2-Mar06.doc – MMT2 Page 1 of 7

Southern Health NHS Foundation Trust POLICIES AND PROCEDURES PROFORMA Subject and Version of Document:

Clinical Supervision Procedure – V1

Author:

Chief Pharmacist

Date agreed:

V1: March 2006

Date of next review/update and by whom:

MMT – March 2011

Amendments Summary: Amend. No.

Issued

Page

Subject

F:\PHARMACISTS\Pharmacists Procedure documents\MMT2 Clinical Supervision Procedure\Clinical Supervision Procedure-MMT2-Mar06.doc – MMT2 Page 2 of 7

Clinical Supervision Procedure Introduction Clinical supervision is a key component of Clinical Governance and is essential to the performance of clinical staff by allowing them time to reflect on clinical practice. The aim of clinical supervision is to: Allow the Pharmacist time to reflect on individual clinical practice in a supportive environment. Allow for personal development by the development of existing skills and the acquisition of new skills. To receive feedback and challenge about the Pharmacist’s individual clinical practice thus enhancing quality of care. Definition Clinical Supervision is a mandatory or negotiated contract between a supervisor and supervisee in which the worker gives an account of his/her work with the express purpose of developing his/her competence in providing the highest quality of care to the patient. The processes involved will include support, skills development, the maintenance or improvement of standards and personal development. Three Main Functions Formative: -

The educational process of developing skills.

Restorative: -

The supportive help for professionals who are working constantly with stress and distress.

Normative: -

The managerial and qualitative aspects of professional practice.

Benefits of Clinical Supervision • • • • • •

Challenges and changes practice Increases autonomy Facilitates conflict resolution Explores self examination Reinforces good practice Provides a catalyst for reflective practice

F:\PHARMACISTS\Pharmacists Procedure documents\MMT2 Clinical Supervision Procedure\Clinical Supervision Procedure-MMT2-Mar06.doc – MMT2 Page 3 of 7

• • • • • • • • • • • •

Demonstrates the value of staff Facilitates the network and sharing of ideas and experiences. Encourages innovation and creativity Increases confidence and assertiveness Enables objectivity Increases communication Facilitates problem solving Enables decision making Creates a learning environment Ensures safe practice Facilitates the development of new knowledge and skills Provides an individual support mechanism.

1. Structure 1.1 All Pharmacists working within the Psychiatric services will undergo clinical supervision. 1.2 The Chief Pharmacist will ensure that each Pharmacist has an allotted clinical supervisor for each round of visits. 1.3 Each Pharmacist will draw up an individual contract with their allotted supervisor as per appendix 1. 1.4 Clinical supervision will take place on six monthly basis but other meetings can be arranged if clinical situations arise as agreed between the supervisor and the supervisee. 1.5 The Chief Pharmacist will ensure that time is made available for Clinical Supervision. 1.6 An audit will be carried out to ensure the effectiveness of the process on an annual basis. 2. Process 2.1 Will consist of a visit by the supervisor to follow the supervisee undertaking their usual clinical duties followed by a meeting held in a private area free from outside distractions. It is not expected that this will take up more than one session. 2.2 The day will be mutually arranged between the two parties. 2.3 Any issues discussed will be confidential except where in the view of the supervisor there is clear concern regarding professional misconduct or patient safety. 2.4 Concerns regarding continuing deficits in clinical practice must be disclosed to the Chief Pharmacist with the full knowledge of the supervisee.

F:\PHARMACISTS\Pharmacists Procedure documents\MMT2 Clinical Supervision Procedure\Clinical Supervision Procedure-MMT2-Mar06.doc – MMT2 Page 4 of 7

2.5 Where the supervisor is concerned as to patient safety immediate disclosure of these concerns must be made. The welfare of the patients supersedes any concerns regarding confidentiality. 2.6 Where an issue arises that is outside the skills of the supervisor and specialist skills are required the supervisor will arrange for the supervisee to meet with a specialist supervisor.

3. Record Keeping 3.1. A record of each session will be taken as set out in appendix 2 3.2. Each Pharmacist will keep a copy of the clinical supervision sessions in their personal CPD folder. These will be kept confidentially but may be required by the Chief Pharmacist in the event of any investigations. 3.3. If concerns are indicated as in points 2.3, 2.4 and 2.5 these must be clearly recorded on the supervision sheet. 3.4. If any difficulties arise between the supervisor and supervisee these must be discussed and a copy of the discussion recorded. 3.5. If a breakdown in the process occurs due to continuing difficulties between both parties the Chief Pharmacist will act as a mediator to resolve the problem. Agreement between the two parties must be obtained for disclosure of any information.

Approved HPT Pharmacists – March06

F:\PHARMACISTS\Pharmacists Procedure documents\MMT2 Clinical Supervision Procedure\Clinical Supervision Procedure-MMT2-Mar06.doc – MMT2 Page 5 of 7

Appendix One Clinical Supervision Agreement Standard Statement Clinical Supervision is an exchange between practicing professionals to enable the development of professional skills.

Supervisee I agree to being supervised by the person named below as my clinical supervisor at a mutually agreed date to watch my clinical practice and to discuss issues that arise from the visit and those I will bring myself to the meeting. I accept that my practice will be supported and challenged, if necessary and I agree to keep an appropriate record of the sessions.

Supervisor I agree to visit the member of staff named below in the capacity of clinical supervisor at a mutually agreed date on a six monthly basis with a meeting lasting approximately one hour. During these sessions we will reflect upon service related issues and I will provide a supportive and challenging environment for the development of the named individual’s professional practice development.

Supporting details: -

Signed……………………………Supervisee

Date………………..

Signed…………………………… Supervisor

Date………………..

Signed……………………………..Chief Pharmacist

Date………………..

Review Date………………………………

F:\PHARMACISTS\Pharmacists Procedure documents\MMT2 Clinical Supervision Procedure\Clinical Supervision Procedure-MMT2-Mar06.doc – MMT2 Page 6 of 7

Appendix Two Clinical Supervision Record Name…………………………………………………………………………………………… Supervisor………………………………………… Date of Session………………………………….. Duration…………………………………………… Issues discussed (To include interventions, problem areas of practice etc.)

Action Plan

Additional Notes

Signed………………………………………………….Supervisee

Signed………………………………………………… Supervisor

F:\PHARMACISTS\Pharmacists Procedure documents\MMT2 Clinical Supervision Procedure\Clinical Supervision Procedure-MMT2-Mar06.doc – MMT2 Page 7 of 7